|
|
|
|
|
13.04.26 - 13:03
|
InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M (PR Newswire)
|
|
|
Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for......
|
|
|
13.04.26 - 13:03
|
CollPlant Issues Letter to Shareholders (PR Newswire)
|
|
|
REHOVOT, Israel, April 13, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary plant-derived recombinant human collagen (rhCollagen), is pleased to issue the following letter......
|
|
|
10.04.26 - 09:30
|
China healthcare stocks outgain Hong Kong market as Middle East roils global investments (SCMP)
|
|
|
China's healthcare sector has been drawing offshore capital to Hong Kong-listed stocks as investors look for safe havens amid global volatility in commodities.
The Hang Seng Healthcare Index, tracking some of China's most innovative pharmaceutical companies including Akeso and Innovent Biologics, has surged about 13 per cent since March 23, outpacing the benchmark Hang Seng Index's about 6 per cent gain over the same period.
“Although the Middle East conflict has created a lot of uncertainty and......
|
|
|
|
|
08.04.26 - 14:33
|
Ondo Global Markets Tokenizes Enlivex′s Ordinary Shares (GlobeNewswire EN)
|
|
|
Nes-Ziona, Israel, April 08, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that Ondo Finance (“Ondo”) has launched ENLVon, the Ondo tokenized representation of ENLV's ordinary shares on Ondo's Global Markets platform....
|
|
|
|
|
|
|
06.04.26 - 15:21
|
NeuroSense Granted Brazilian Patent Covering PrimeC Composition (PR Newswire)
|
|
|
Patent Protection Through October 2042 Follows prior patent grants in the U.S. and Australia Further strengthens NeuroSense's global intellectual property portfolio CAMBRIDGE, Mass., April 6, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"),......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
